Primary Site >> Liver Cancer
Gene >> ERBB3
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Cross-talk between phorbol ester-mediated signaling and tyrosine kinase proto-oncogenes. I. Activation of protein kinase C stimulates tyrosine phosphorylation and activation of ErbB2 and ErbB3. PMID: 9388271 |
Ref: Identification of discriminators of hepatoma by gene expression profiling using a minimal dataset approach. PMID: 15057898 |
Ref: Expression of ErbB receptor proteins and TGF-alpha during diethylnitrosamine-induced hepatocarcinogenesis in the rat liver. PMID: 17380077 |
Ref: Epithelial-to-mesenchymal transition and integrin-linked kinase mediate sensitivity to epidermal growth factor receptor inhibition in human hepatoma cells. PMID: 18381447 |
Ref: Insulin-like growth factor-1 receptor inhibition induces a resistance mechanism via the epidermal growth factor receptor/HER3/AKT signaling pathway: rational basis for cotargeting insulin-like growth factor-1 receptor and epidermal growth factor receptor PMID: 19706799 Ref: Vascular Endothelial Growth Factor Receptor-1 Is Synthetic Lethal to Aberrant {beta}-Catenin Activation in Colon Cancer. PMID: 20008853 |
Ref: Significance of integrin alphavbeta5 and erbB3 in enhanced cell migration and liver metastasis of colon carcinomas stimulated by hepatocyte-derived heregulin. PMID: 20626753 |
Ref: Neuregulin/erythroblastic leukemia viral oncogene homolog 3 autocrine loop contributes to invasion and early recurrence of human hepatoma. PMID: 21246584 Ref: Secreted ERBB3 isoforms are serum markers for early hepatoma in patients with chronic hepatitis and cirrhosis. PMID: 21877752 Ref: Use of protein array technology to investigate receptor tyrosine kinases activated in hepatocellular carcinoma. PMID: 22977516 |
Ref: Novel nonphosphorylated peptides with conserved sequences selectively bind to Grb7 SH2 domain with affinity comparable to its phosphorylated ligand. PMID: 22253820 |
Ref: New routes to targeted therapy of intrahepatic cholangiocarcinomas revealed by next-generation sequencing. PMID: 24563076 Ref: The downregulation of ErbB3 binding protein 1 (EBP1) is associated with poor prognosis and enhanced cell proliferation in hepatocellular carcinoma. PMID: 25081333 |
Ref: The EGFR/ErbB3 Pathway Acts as a Compensatory Survival Mechanism upon c-Met Inhibition in Human c-Met+ Hepatocellular Carcinoma. PMID: 26000702 Ref: N'-Alkylaminosulfonyl Analogues of 6-Fluorobenzylideneindolinones with Desirable Physicochemical Profiles and Potent Growth Inhibitory Activities on Hepatocellular Carcinoma. PMID: 26214403 Ref: Novel carbocyclic curcumin analog CUR3d modulates genes involved in multiple apoptosis pathways in human hepatocellular carcinoma cells. PMID: 26409325 Ref: Loss of hepatocyte ERBB3 but not EGFR impairs hepatocarcinogenesis. PMID: 26492920 |
Ref: HBx sensitizes hepatocellular carcinoma cells to lapatinib by up-regulating ErbB3. PMID: 26595522 Ref: Hepatitis B virus X protein reduces the stability of Nrdp1 to up-regulate ErbB3 in hepatocellular carcinoma cells. PMID: 26846102 Ref: Heregulin-1ss and HER3 in hepatocellular carcinoma: status and regulation by insulin. PMID: 27514687 Ref: Genomic characterization of liver metastases from colorectal cancer patients. PMID: 27662660 Ref: Erratum to: Heregulin-1ss and HER3 in hepatocellular carcinoma: status and regulation by insulin. PMID: 27680564 |
Ref: MicroRNA-125a-5p Inhibits Cell Proliferation and Induces Apoptosis in Hepatitis B Virus-Related Hepatocellular Carcinoma by Downregulation of ErbB3. PMID: 28800792 Ref: Telmisartan inhibits hepatocellular carcinoma cell proliferation in vitro by inducing cell cycle arrest. PMID: 29048654 |
Ref: Reduced expression of Nrdp1 predicts a poor prognosis in human hepatocellular carcinoma. PMID: 30154664 |